drugset / Trial / NCT04230980

Gabapentin for Post-Operative Pain Control and Narcotic Reduction in Scrotal Surgery

NCT04230980

Phase 3 Completed 74 enrolled Weill Medical College of Cornell University
RandomizedParallel-groupDouble-blindTreatment

Summary

The use of non-narcotic multi-modal analgesia to be used in the pre-operative, peri-operative and post-operative period to reduce or potentially eliminate narcotic usage following scrotal surgery. Research study results have shown that the use of anti-inflammatories in the peri-operative period reduces both pain and narcotic use. The hypothesis is that adding another agent in the multi-modal pathway will further reduce pain and potentially reduce narcotic usage.

Timeline

Start
2020-07-28
Primary completion
2022-11-28
Completion
2022-12-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 300 mg

Indications